
Stéphane Bancel
Vermögen: 1 052 Mio $ am 31.05.2026

Vermögen: 1 052 Mio $ am 31.05.2026
Stphane Bancel ist ein Geschäftsmann, der bereits 5 verschiedene Unternehmen geleitet hat. Gegenwärtig bekleidet er die Position des Chief Executive Officer & Director bei Moderna, Inc, Chief Executive Officer & Director bei ModernaTX, Inc. (eine Tochtergesellschaft von Moderna, Inc.) und Chief Executive Officer bei Moderna SpA. Herr Bancel ist außerdem im Vorstand von 5 weiteren Unternehmen. In seiner früheren Laufbahn hatte Stphane Bancel die Position des Chairman bei BG Medicine, Inc. inne, Executive Director-Global Manufacturing Strategy bei Eli Lilly & Co. Principal bei Eli Lilly & Co. Ltd. und Managing Director bei Eli Lilly Benelux SA (beides Tochtergesellschaften von Eli Lilly & Co.) sowie Chief Executive Officer bei bioMrieux SA. Stphane Bancel erhielt einen Abschluss der University of Minnesota, einen Abschluss der Cole Centrale Paris und einen MBA der Harvard Business School.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MODERNA, INC. 5.54% | 09.03.2026 | 21’963’357 ( 5.54% ) | 1 036 Mio $ | 31.05.2026 |
| 02.03.2026 | 1’184’989 ( 0.92% ) | 16 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| MODERNA, INC. | Vorstandsvorsitzender | 01.03.2011 |
| GENERATE BIOMEDICINES, INC. | Direktor/Vorstandsmitglied | 01.09.2019 |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Private Equity Investor | 01.01.2013 |
Moderna SpA
Moderna SpA Food DistributorsDistribution Services Wholesales food and non-food products | Vorstandsvorsitzender | - |
Qiagen SRL
Qiagen SRL Medical SpecialtiesHealth Technology Provides molecular testing solutions | Direktor/Vorstandsmitglied | - |
Indigo Ag, Inc.
Indigo Ag, Inc. BiotechnologyHealth Technology Develops biological and digital technologies | Direktor/Vorstandsmitglied | 02.08.2020 |
Museum of Science
Museum of Science Other Consumer ServicesConsumer Services Operates as a museum | Direktor/Vorstandsmitglied | - |
QIAGEN GmbH
QIAGEN GmbH Miscellaneous Commercial ServicesCommercial Services Provides products for preanalytical sample preparation and molecular diagnostics solutions | Direktor/Vorstandsmitglied | - |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Develops messenger RNA therapeutics | Vorstandsvorsitzender | - |
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 23 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
QIAGEN NV
QIAGEN NV Medical SpecialtiesHealth Technology Manufactures and distributes sample and assay technology products for pre-analytical sample preparations | Health Technology |
Biotheranostics, Inc.
Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Discovers, develops and commercializes molecular diagnostic tests for cancer patients | Health Services |
BG Medicine, Inc.
BG Medicine, Inc. Medical SpecialtiesHealth Technology Develops and manufactures diagnostic test kits | Health Technology |
Targanta Therapeutics Corp.
Targanta Therapeutics Corp. BiotechnologyHealth Technology Discovers and develops novel antibacterial pro drugs | Health Technology |
Tafkak, Inc.
Tafkak, Inc. Miscellaneous Commercial ServicesCommercial Services Provides genome sequencing and analysis solutions | Commercial Services |
bioMérieux SA
bioMérieux SA Medical SpecialtiesHealth Technology Develops biotechnological products specializing in in-vitro diagnostics and infectious diseases | Health Technology |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
University of Minnesota
University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eli Lilly & Co. Ltd.
Eli Lilly & Co. Ltd. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical health care solutions | Health Technology |
QIAGEN GmbH
QIAGEN GmbH Miscellaneous Commercial ServicesCommercial Services Provides products for preanalytical sample preparation and molecular diagnostics solutions | Commercial Services |
École Centrale Paris
École Centrale Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Museum of Science
Museum of Science Other Consumer ServicesConsumer Services Operates as a museum | Consumer Services |
Eli Lilly Benelux SA
Eli Lilly Benelux SA Pharmaceuticals: MajorHealth Technology Engages in discovery and development of medicines | Health Technology |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Develops messenger RNA therapeutics | Health Technology |
Qiagen SRL
Qiagen SRL Medical SpecialtiesHealth Technology Provides molecular testing solutions | Health Technology |
Syros Pharmaceuticals, Inc.
Syros Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which developing care for the frontline treatment of patients with hematologic malignancies | Health Technology |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indigo Ag, Inc.
Indigo Ag, Inc. BiotechnologyHealth Technology Develops biological and digital technologies | Health Technology |
Moderna, Inc.
Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
Moderna SpA
Moderna SpA Food DistributorsDistribution Services Wholesales food and non-food products | Distribution Services |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Operates as a clinical-stage generative biology company that provides biotechnology and drug design & development services | Health Technology |
Moderna Holding BV
Moderna Holding BV MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen